$47.94
9.90% day before yesterday
Nasdaq, Dec 20, 10:05 pm CET
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Twist Bioscience Corp. Target price 2024 - Analyst rating & recommendation

Twist Bioscience Corp. Classifications & Recommendation:

Buy
83%
Hold
8%
Sell
8%

Twist Bioscience Corp. Price Target

Target Price $53.09
Price $47.94
Potential
Number of Estimates 11
11 Analysts have issued a price target Twist Bioscience Corp. 2025 . The average Twist Bioscience Corp. target price is $53.09. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 10 Analysts recommend Twist Bioscience Corp. to buy, 1 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Twist Bioscience Corp. stock has an average upside potential 2025 of . Most analysts recommend the Twist Bioscience Corp. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Million $ 312.97 373.28
27.69% 19.27%
EBITDA Margin -46.16% -32.23%
36.29% 30.18%
Net Margin -67.73% -39.12%
21.68% 42.24%

11 Analysts have issued a sales forecast Twist Bioscience Corp. 2025 . The average Twist Bioscience Corp. sales estimate is

$373m
Unlock
. This is
19.27% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$376m 20.14%
Unlock
, the lowest is
$371m 18.41%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $313m 27.69%
2025
$373m 19.27%
Unlock
2026
$439m 17.48%
Unlock
2027
$528m 20.46%
Unlock
2028
$624m 18.20%
Unlock
2029
$720m 15.33%
Unlock

6 Analysts have issued an Twist Bioscience Corp. EBITDA forecast 2025. The average Twist Bioscience Corp. EBITDA estimate is

$-120m
Unlock
. This is
16.73% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-112m 22.61%
Unlock
, the lowest is
$-138m 4.49%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-144m 18.65%
2025
$-120m 16.73%
Unlock
2026
$-87.9m 26.94%
Unlock
2027
$-33.8m 61.57%
Unlock
2028
$-3.3m 90.23%
Unlock
2029
$19.0m 675.76%
Unlock

EBITDA Margin

2024 -46.16% 36.29%
2025
-32.23% 30.18%
Unlock
2026
-20.04% 37.82%
Unlock
2027
-6.40% 68.06%
Unlock
2028
-0.53% 91.72%
Unlock
2029
2.64% 598.11%
Unlock

5 Twist Bioscience Corp. Analysts have issued a net profit forecast 2025. The average Twist Bioscience Corp. net profit estimate is

$-146m
Unlock
. This is
31.11% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-138m 35.00%
Unlock
, the lowest is
$-165m 21.95%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-212m 0.00%
2025
$-146m 31.11%
Unlock
2026
$-108m 25.72%
Unlock
2027
$-65.5m 39.61%
Unlock
2028
$-51.2m 21.79%
Unlock
2029
$-36.5m 28.73%
Unlock

Net Margin

2024 -67.73% 21.68%
2025
-39.12% 42.24%
Unlock
2026
-24.73% 36.78%
Unlock
2027
-12.40% 49.86%
Unlock
2028
-8.20% 33.87%
Unlock
2029
-5.07% 38.17%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Earnings Per Share $ -3.60 -2.48
0.00% 31.11%
P/E negative
EV/Sales 7.11

5 Analysts have issued a Twist Bioscience Corp. forecast for earnings per share. The average Twist Bioscience Corp. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-2.48
Unlock
. This is
31.11% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-2.34 35.00%
Unlock
, the lowest is
$-2.81 21.94%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-3.60 0.00%
2025
$-2.48 31.11%
Unlock
2026
$-1.84 25.81%
Unlock
2027
$-1.11 39.67%
Unlock
2028
$-0.87 21.62%
Unlock
2029
$-0.62 28.74%
Unlock

P/E ratio

Current -13.32 38.46%
2025
-19.33 45.12%
Unlock
2026
-26.03 34.66%
Unlock
2027
-43.09 65.54%
Unlock
2028
-55.10 27.87%
Unlock
2029
-77.32 40.33%
Unlock

Based on analysts' sales estimates for 2025, the Twist Bioscience Corp. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.48 18.60%
2025
7.11 16.15%
Unlock
2026
6.05 14.88%
Unlock
2027
5.02 16.98%
Unlock
2028
4.25 15.40%
Unlock
2029
3.69 13.30%
Unlock

P/S ratio

Current 9.09 11.65%
2025
7.62 16.16%
Unlock
2026
6.49 14.88%
Unlock
2027
5.39 16.98%
Unlock
2028
4.56 15.40%
Unlock
2029
3.95 13.29%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today